B. Kroon

发表

Radio-guided surgery improves outcome of therapeutic excision in non-palpable invasive breast cancer

E. Deurloo, P. Tanis, J. F. Gallegos Hernández, 2004, Nuclear medicine communications.

Isolated limb perfusion with high-dose tumor necrosis factor-α for locally advanced extremity soft tissue sarcomas

P. Schlag, A. Eggermont, B. Kroon, 1997 .

Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage

E. Rutgers, P. Tanis, O. Nieweg, 2001, Nuclear medicine communications.

Status of Lymph Node Staging

E. Rutgers, E. Deurloo, O. Nieweg, 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

A. Paradiso, P. Johnston, A. Eggermont, 2022 .

Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy.

P. Tanis, O. Nieweg, B. Kroon, 2001, Journal of the American College of Surgeons.

Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature.

I. V. D. van der Ploeg, O. Nieweg, B. Kroon, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients

J. Peterse, E. Rutgers, E. Rutgers, 2002, British Journal of Cancer.

Hyperthermic isolated limb perfusion with tumour necrosis factor and melphalan as treatment of locally advanced or recurrent soft tissue sarcomas of the extremities.

H. Hoekstra, A. V. van Geel, A. Eggermont, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hyperthermic isolated limb perfusion for the treatment of soft tissue sarcomas.

H. Hoekstra, A. V. van Geel, A. Eggermont, 1998, Seminars in surgical oncology.

False negative sentinel node procedure established through palpation of the biopsy wound.

J. Peterse, P. Tanis, O. Nieweg, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Technique of sentinel node biopsy in breast cancer.

E. Rutgers, O. Nieweg, B. Kroon, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Carbon dioxide laser for cutaneous melanoma metastases: indications and limitations.

O. Nieweg, B. Kroon, L. Strobbe, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Principles and guidelines for surgeons: management of cutaneous malignant melanoma. European Society of Surgical Oncology Brussels.

H. Hoekstra, O. Nieweg, B. Kroon, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Thirty‐five years of isolated limb perfusion for melanoma: Indications and results

B. Vrouenraets, O. Nieweg, B. Kroon, 1996, The British journal of surgery.

Safety and efficacy of isolated limb perfusion in elderly melanoma patients

A. Eggermont, B. Vrouenraets, O. Nieweg, 2002, Annals of Surgical Oncology.

Systemic toxicity after isolated limb perfusion with melphalan for melanoma.

A. Eggermont, B. Vrouenraets, J. Klaase, 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Isolated limb perfusion with melphalan for femoral metastases of breast cancer: Case report

B. Vrouenraets, O. Nieweg, B. Kroon, 2002, Journal of surgical oncology.

Isolated Limb Perfusion: The European Experience

A. Eggermont, H. Hoekstra, B. Kroon, 2001 .

Isolated limb perfusion in primary and recurrent melanoma: indications and results.

A. Eggermont, A. Eggermont, B. Kroon, 1998, Seminars in surgical oncology.

Rationale for using TNFα and chemotherapy in regional therapy of melanoma

A. Eggermont, A. Eggermont, P. Schmitz, 1994 .

Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma.

A. Vilalta, O. Nieweg, B. Kroon, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The illusion of the learning phase for lymphatic mapping

A. Hart, P. Tanis, O. Nieweg, 2002, Annals of Surgical Oncology.

Sensitivity of sentinel node biopsy in melanoma

P. Tanis, O. Nieweg, B. Kroon, 2001, Journal of surgical oncology.

Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma.

I. Liem, O. Nieweg, B. Kroon, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Isolated internal mammary sentinel lymph node metastasis in two breast cancer patients

E. Rutgers, P. Tanis, O. Nieweg, 2002, International Journal of Clinical Oncology.

Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.

A. Eggermont, P. Schmitz, J. Gérain, 1995, The Journal of infusional chemotherapy.

Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma.

A. Hart, L. Strobbe, B. Kroon, 1997 .

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study.

A. Eggermont, P. Schmitz, B. Kroon, 1999, Melanoma research.

Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study.

A. Eggermont, P. Autier, B. Kroon, 1994, Melanoma research.

Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer

F. Zoetmulder, E. Rutgers, B. Kroon, 1996, The British journal of surgery.

Sentinel-node biopsy in breast cancer

B. Kroon, L. Jansen, O. Nieweg, 1997, The Lancet.

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.

A. Eggermont, H. Hoekstra, A. V. van Geel, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphatic mapping with tracer administration into the primary breast cancer.

E. Rutgers, O. Nieweg, B. Kroon, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study.

A. Eggermont, H. Hoekstra, A. Eggermont, 1999, Archives of surgery.

Reproducibility study of lymphoscintigraphy: Excisional biopsy of breast lesions changes drainage patterns

E. Rutgers, O. Nieweg, B. Kroon, 2004, Annals of Surgical Oncology.

Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma.

W. Mooi, O. Nieweg, B. Kroon, 2008, Anticancer research.

Thin Stage I Primary Cutaneous Malignant Melanoma

C. Balch, N. Cascinelli, U. Veronesi, 1988 .

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

P. Schlag, A. Eggermont, H. Hoekstra, 1996, Annals of surgery.

The sentinel node procedure in patients with melanoma.

O. Nieweg, B. Kroon, S. H. Estourgie, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, a

A. Eggermont, J. Thompson, A. Eggermont, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Guideline 'Melanoma' (3rd revision)].

O. Nieweg, B. Kroon, 2005, Nederlands tijdschrift voor geneeskunde.

N. Aaronson, M. Muller, B. Vrouenraets, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics.

A. V. van Geel, B. Kroon, A. N. Geel, 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Regional Isolated Limb Perfusion in Patients with Malignant Melanoma

A. Eggermont, J. Zee, B. Vrouenraets, 1993 .

Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.

A. Hart, A. V. van Geel, A. Eggermont, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma.

A. Eggermont, B. Vrouenraets, J. Klaase, 1999, Journal of the American College of Surgeons.

Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb.

J. Beijnen, J. Klaase, B. Kroon, 1994, British Journal of Cancer.

Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.

A. Eggermont, B. Vrouenraets, J. Klaase, 1996, Journal of the American College of Surgeons.

High dose tumor necrosis factor alpha in isolation perfusion of the limb : highly effective treatment for melanoma in transit metastases or unresectable sarcomas

A. Eggermont, P. Schmitz, B. Kroon, 1995 .

Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma.

A. Eggermont, P. Schmitz, J. Gérain, 1994, Circulatory shock.

Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan.

B. Vrouenraets, O. Nieweg, B. Kroon, 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbs.

A. Eggermont, B. Vrouenraets, J. Klaase, 1994, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.

A. Eggermont, A. V. van Geel, B. Vrouenraets, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Isolated limb perfusion for melanoma: technical aspects

B. Kroon, J. Klaase, H. Koops, 2003 .

Relation between calculated melphalan peak concentrations and toxicity in regional isolated perfusion for melanoma

J. Klaase, B. Kroon, C. Benckhuijsen, 1992 .

Rationale for different approaches to combined melphalan and hyperthermia in regional isolated perfusion.

J. van der Zee, H. Kampinga, O. Nieweg, 1997, European journal of cancer.

Major amputation for intractable extremity melanoma after failure of isolated limb perfusion.

A. Eggermont, A. V. van Geel, B. Vrouenraets, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Comparison between the use of whole blood versus a diluted perfusate in regional isolated perfusion by continuous monitoring of transcutaneous oxygen tension: a pilot study.

J. van der Zee, J. Klaase, B. Kroon, 1994, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

Reliability of sentinel lymph node biopsy for staging melanoma

J. Peterse, O. Nieweg, B. Kroon, 2000, The British journal of surgery.

Prognostic factors for survival after isolated limb perfusion for malignant melanoma.

A. Eggermont, A. V. van Geel, B. Vrouenraets, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Physiological implications of hyperbaric oxygen tensions in isolated limb perfusion using melphalan: a pilot study.

J. van der Zee, B. Vrouenraets, O. Nieweg, 1996, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

Absence of severe systemic toxicity after leakage controlled isolated limb perfusion (ILP) with high-dose TNF?? + melphalan: 387

A. Eggermont, B. Vrouenraets, A. Ogilvie, 1997 .

Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma

B. Vrouenraets, J. Klaase, O. Nieweg, 1995, Melanoma research.

Value of prophylactic isolated limb perfusion (ILP) for stage I high risk malignant melanoma: a randomised phase III trial

A. Eggermont, B. Kroon, F. Lejeune, 1997 .

Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs.

A. V. van Geel, B. Kroon, J. Wieberdink, 1987, Anticancer research.

Preliminary Results of a Double Perfusion Schedule with Melphalan in Measurable Melanoma

J. Klaase, B. Kroon, A. N. Geel, 1990 .

Results of a double perfusion schedule using high-dose hyperthermia and melphalan sequentially for recurrent melanoma of the limbs: a pilot study

J. Zee, J. Klaase, B. Kroon, 1992 .

[Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience].

A. Eggermont, P. Schmitz, J. Gérain, 1995, Bulletin du Cancer.

Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas.

P. Schlag, A. Eggermont, B. Kroon, 1997, Seminars in oncology.

Temperature distribution and pH changes during hyperthermic regional isolation perfusion.

A. Hagenbeek, J. van der Zee, B. Kroon, 1989, European journal of cancer & clinical oncology.

Technique of lymphatic mapping and sentinel node biopsy for melanoma.

O. Nieweg, B. Kroon, O E Nieweg, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas.

P. Schlag, A. Eggermont, B. Kroon, 1997, Cancer treatment and research.

Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy.

J. Thompson, O. Nieweg, B. Kroon, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Validation of gamma probe detection of the sentinel node in melanoma.

S H Muller, E. Rutgers, I. Liem, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Can Histologic Parameters of Melanoma Metastases in Sentinel Lymph Nodes Reliably Select Patients Who Can Be Safely Spared Completion Lymph Node Dissection

O. Nieweg, B. Kroon, R. Olmos, 2010 .

Limb salvage (LS) by isolated limb perfusion (ILP) with TNF and melphalan (M) In 246 patients with advanced soft tissue sarcomas (STS): Results of 270 ILPS in 246 pts

P. Schlag, A. Eggermont, B. Kroon, 1999 .

Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.

S H Muller, E. Rutgers, O. Nieweg, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The sentinel node biopsy in patients with breast cancer; many controversies remain.

E. Rutgers, H. Oldenburg, O. Nieweg, 2006, European journal of gynaecological oncology.

Authors' reply

O. Nieweg, B. Kroon, C. Hoefnagel, 2000, The British journal of surgery.

637 Results of sentinel node biopsy in cutaneous melanoma

W. Mooi, I. Liem, B. Kroon, 1995 .

Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial

T. D. de Reijke, K. Aben, H. V. van Melick, 2018, Contemporary clinical trials communications.

Perfusion using high dose hyperthermia and melphalan sequentially for recurrent melanoma of the limbs: 348

J. Zee, J. Klaase, B. Kroon, 1993 .

IL-34 Sentinel Node Biopsy as Standard of Care in Melanoma?

O. Nieweg, B. Kroon, S. H. Estourgie, 2003 .

Sentinel nodes outside lymph node basins in patients with melanoma

O. Nieweg, B. Kroon, L. Jansen, 2001, The British journal of surgery.

Quality of life in long-term survivors after isolated limb perfusion for melanoma of the limbs

N. Aaronson, M. Muller, B. Vrouenraets, 2004, Annals of Surgical Oncology.

The hidden sentinel node in breast cancer

J. V. van Sandick, P. Tanis, E. Rutgers, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Eight false negative sentinel node procedures in breast cancer: what went wrong?

J. Peterse, E. Rutgers, O. Nieweg, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy.

J. Peterse, E. Rutgers, O. Nieweg, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Accuracy of lymphoscintigraphy in indicating the number of sentinel lymph nodes: 102

O. Nieweg, B. Kroon, R. Olmos, 1997 .

High tPA-expression in primary melanoma of the limb correlates with good prognosis

A. Eggermont, U. Kleeberg, H. Straatman, 2000, British Journal of Cancer.

Report of a symposium on: diagnosis and treatment of cutaneous head and neck melanoma.

W. Mooi, B. Kroon, E. Rankin, 1994, European Journal of Surgical Oncology.

Excision biopsy of breast lesions changes the pattern of lymphatic drainage

O. Nieweg, B. Kroon, R. V. Valdés Olmos, 2007, The British journal of surgery.

Dermatofibrosarcoma protuberans: treatment and prognosis.

E. Rutgers, B. Kroon, B. Kroon, 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[The role of sentinel node biopsies in the treatment of patients with breast carcinoma].

E. Rutgers, J. Peterse, O. Nieweg, 1996, Nederlands tijdschrift voor geneeskunde.

A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities.

A. Hart, A. V. van Geel, A. Eggermont, 1995, European journal of cancer.

Lymph node metastasis from melanoma with an unknown primary site

A. Hart, W. Mooi, J. V. Dongen, 1990, The British journal of surgery.

Systemic leakage during isolated limb perfusion for melanoma

A. Eggermont, J. Klaase, B. Kroon, 1993, The British journal of surgery.

Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma

B. Kroon, P. Rümke, L. Strobbe, 1997, Melanoma research.

Identification and biopsy of the sentinel lymph node in breast cancer.

A. Hart, E. Rutgers, J. V. Dongen, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.